- Conditions
- Coronary Heart Disease
- Interventions
- Placebo, dalcetrapib
- Drug
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 135 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2008
- U.S. locations
- 10
- States / cities
- Chicago, Illinois • Indianapolis, Indiana • Iowa City, Iowa + 6 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–10
of 10
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Dyslipidemia
- Interventions
- Placebo, Pravastatin, Dalcetrapib
- Drug
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 292 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2006
- U.S. locations
- 33
- States / cities
- Mobile, Alabama • Scottsdale, Arizona • Newark, Delaware + 30 more
- Conditions
- Coronary Heart Disease
- Interventions
- dalcetrapib (RO4607381), placebo
- Drug
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 77 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2008
- U.S. locations
- 9
- States / cities
- Indianapolis, Indiana • Iowa City, Iowa • Louisville, Kentucky + 5 more
- Conditions
- Coronary Heart Disease
- Interventions
- Dalcetrapib (RO4607381), Evidence-based medical care for Acute Coronary Syndrome, Placebo
- Drug
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Eligibility
- 45 Years and older
- Enrollment
- 15,871 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2012
- U.S. locations
- 513
- States / cities
- Birmingham, Alabama • Mobile, Alabama • Tuscaloosa, Alabama + 400 more
- Conditions
- Acute Coronary Syndrome
- Interventions
- Dalcetrapib, Placebo
- Drug
- Lead sponsor
- DalCor Pharmaceuticals
- Industry
- Eligibility
- 45 Years and older
- Enrollment
- 2,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2027
- U.S. locations
- 186
- States / cities
- Alexander City, Alabama • Birmingham, Alabama • Fairhope, Alabama + 163 more
- Conditions
- Acute Coronary Syndrome
- Interventions
- dalcetrapib, Placebo
- Drug
- Lead sponsor
- DalCor Pharmaceuticals
- Industry
- Eligibility
- 45 Years and older
- Enrollment
- 6,147 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2021
- U.S. locations
- 122
- States / cities
- Alexander City, Alabama • Huntsville, Alabama • Mobile, Alabama + 119 more
- Conditions
- Coronary Heart Disease
- Interventions
- dalcetrapib, placebo
- Drug
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Eligibility
- 45 Years and older
- Enrollment
- 300 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2012
- U.S. locations
- 6
- States / cities
- Pensacola, Florida • Saginaw, Michigan • Saint Cloud, Minnesota + 2 more
- Conditions
- Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD)
- Interventions
- Background care, Placebo, dalcetrapib
- Other · Drug
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Eligibility
- 45 Years and older
- Enrollment
- 2,220 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012
- U.S. locations
- 121
- States / cities
- Birmingham, Alabama • Huntsville, Alabama • Anaheim, California + 112 more
- Conditions
- Cardiovascular Disease
- Interventions
- Dalcetrapib, Placebo
- Drug
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 936 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2011
- U.S. locations
- 41
- States / cities
- Los Angeles, California • Torrance, California • Boulder, Colorado + 36 more
- Conditions
- Coronary Heart Disease
- Interventions
- Dalcetrapib (RO4607381), Placebo
- Drug
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 130 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2010
- U.S. locations
- 11
- States / cities
- Jacksonville, Florida • Royal Oak, Michigan • Minneapolis, Minnesota + 7 more